| Financial Year |
March 31 2023 |
| Monetary Funds |
599,522,697.14 |
| Held-for-trading Financial Assets |
8,107,919.90 |
| Notes Receivable |
94,333,819.99 |
| Accounts Receivable |
828,716,519.01 |
| Advances to Suppliers |
128,197,949.71 |
| Other Receivables |
80,559,265.36 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,001,268,557.95 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
16,590,060.16 |
| Total Current Assets |
2,855,373,860.61 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
21,994,715.09 |
| Investment Properties |
-- |
| Fixed Assetes |
291,978,398.11 |
| Under-construction Projects |
116,314,833.02 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
276,361,698.19 |
| R&D expenses |
128,310,810.37 |
| Goodwill |
26,833,332.91 |
| Long-Term Deferred and Prepaid Expenses |
43,755,879.19 |
| Deferred Income Tax Assets |
63,026,589.21 |
| Other Non-Current Assets |
14,145,859.81 |
| Sub-Total of Non-Current Assets |
1,064,256,550.73 |
| Total Assets |
3,919,630,411.34 |
| Short-Term Loans |
620,382,757.68 |
| Trading Financial liabilities |
-- |
| Notes Payable |
94,788,353.90 |
| Accounts Payable |
629,082,817.43 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
19,838,280.07 |
| Taxes Payable |
10,253,200.71 |
| Interest Payable |
518,090.84 |
| Dividend Payable |
-- |
| Other payables |
41,352,177.06 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
65,054,448.39 |
| Other Current Liabilities |
30,230,771.33 |
| Sub-Total of Current Liabilities |
1,657,832,172.93 |
| Long-term Loans |
185,295,984.17 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
5,591,040.66 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
450,083,859.83 |
| Total Liabilities |
2,107,916,032.76 |
| Paid-In Capital(Or Share Stock) |
198,696,906.00 |
| Capital Surplus |
1,145,617,451.97 |
| Surplus Reserve |
51,713,680.66 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
211,577,486.73 |
| Minority Stockholder's Interest |
204,090,657.62 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,607,623,720.96 |
| Owner's Equity（Stockholder's Equity） |
1,811,714,378.58 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,919,630,411.34 |
